SCOTT JOHN K JR. received a stock award from NAVIDEA BIOPHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/15/2023ACC: 0001437749-23-017587
10% Owner
Since Sep 2018
+11.51M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
11.52M acquired · 12.96K disposed
Non-Derivative Transactions2
Series G Redeemable Preferred Stock
Direct
Shares
−990.00
Price / share
—
Trade value
—
% of position
30.4%
6/1/2023
3.26K→2.27K
Common Stock
Direct
Shares
+11.51M
Price / share
—
Trade value
—
% of position
143.0%
6/5/2023
8.05M→19.56M
Total
Net shares
+11.51M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Series G Redeemable Preferred Stock Direct | 6/1/2023 | J · J | −990.00 | — | — | 30.4% | 3.26K | 2.27K |
| Common Stock Direct | 6/5/2023 | A · Award | +11.51M | — | — | 143.0% | 8.05M | 19.56M |
| Total | +11.51M | $0.00 | ||||||
Derivative Transactions2
Series J Convertible Preferred Stock
Direct
Converts to
Common Stock
11.51M shares
Shares
+11.97K
Strike price
0.1040
Held after
11.97K
Exercisable
—
6/1/2023
Series J Convertible Preferred Stock
Direct
Converts to
Common Stock
11.51M shares
Shares
−11.97K
Strike price
0.1040
Held after
0.00
Exercisable
—
6/5/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series J Convertible Preferred Stock Direct | Common Stock11.51M shares | 6/1/2023 | P · Purchase | +11.97K | 0.1040 | — | 11.97K |
| Series J Convertible Preferred Stock Direct | Common Stock11.51M shares | 6/5/2023 | C · Conversion | −11.97K | 0.1040 | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned10.14K
Total
10.14K indirect10.14K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 10.14K | Indirect |
| Total | 10.14K | 10.14K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported